Company Filing History:
Years Active: 2019
Title: Innovations in Cancer Prognosis by Si Eun Kim
Introduction
Si Eun Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer research, particularly in the prognosis of early-stage breast cancer. His innovative work focuses on genetic analysis to improve patient outcomes and reduce unnecessary treatments.
Latest Patents
Si Eun Kim holds a patent for a groundbreaking invention titled "Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the same." This invention relates to a method for selecting a gene intended to predict cancer prognosis. It includes a kit for predicting metastasis in breast cancer patients. The method utilizes genetic characteristics to achieve high-reliability predictions of patient prognosis, thereby enhancing prognosis diagnosis and minimizing unnecessary anticancer therapy. He has 1 patent to his name.
Career Highlights
Si Eun Kim is associated with Gencurix Inc., a company dedicated to advancing cancer diagnostics and treatment. His work at Gencurix has positioned him as a key player in the development of innovative solutions for cancer prognosis.
Collaborations
Si Eun Kim has collaborated with notable colleagues in his field, including Young Kee Shin and Young-Deug Kim. Their combined expertise contributes to the advancement of cancer research and the development of effective diagnostic tools.
Conclusion
Si Eun Kim's contributions to cancer prognosis through genetic analysis represent a significant advancement in medical science. His innovative approach has the potential to improve patient care and outcomes in breast cancer treatment.